4-브로모(1H)인다졸

4-bromo-1H-indazole

HCID 22352548

기본 정보

CAS
186407-74-9
표준 SMILES
Brc1cccc2[nH]ncc12
InChIKey
KJIODOACRIRBPB-UHFFFAOYSA-N
분자식
C7H5BrN2
평균 분자량
197.03 g/mol
단동위원소 질량
195.96361026

이름 및 식별자

우선 이름
4-bromo-1H-indazole
IUPAC
4-bromo-1H-indazole
현지명
4-브로모(1H)인다졸
영어명
4-Bromo-1H-indazole
분자식
C7H5BrN2
분자량
197.03

이름 및 동의어

4-bromo-1H-indazole186407-74-9DTXSID30625169RefChem:98011DTXCID20575922803-241-74-Bromoindazole1H-Indazole, 4-bromo-4-BROMO (1H)INDAZOLEMFCD056640014-Bromo(1H)indazole4-bromo-2H-indazole
이름 더 보기
4-브로모(1H)인다졸broMo-1H-indazole4-Bromoindazole >4-BroMo-1H-indazole, 97+%4-bromo-1H-indazole£4-Bromoindazole
CHEMBL2463934-bromanyl-1H-indazole4-bromo-indazoleKX3GM9K3FXSCHEMBL155255SCHEMBL5581824-Bromo-1H-indazole, 95%orb2940507

데이터베이스 식별자

CAS
186407-74-9
PubChem CID
22352548
DTXSID
DTXSID30625169
ChEMBL
CHEMBL246393
UNII
KX3GM9K3FX
EC Number
803-241-7
Nikkaji
J2.390.678C

물성

구조 계산 물성

XLogP
2.2
극성 표면적
28.7 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
1
회전 가능 결합 수
0
무거운 원자 수
10

물리화학적 성질

녹는점
165 · 165-167°
끓는 점
333.8 · 333.8±15.0 °C(Predicted)
밀도
1.77 · 1.770±0.06 g/cm3(Predicted)
저장 조건
2 · 2-8°C
용해도
에탄올에 용해됨
물리적 상태
고체

화학적 성질

brown powder

안전 및 규제

GHS 분류

GHS Classification · 4건

Danger

H301 (93.5%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 46 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 3 (93.5%)

안전 데이터

wgk
3
ridadr
2811
HS 번호
2933998090
risk_code
25-36/37/38
hazard_code
Xi,T
safety_code
26-45

화학 및 산업

응용 분야 · 1건

개요4-Bromo-1H-indazole is a derivative indazole which has a heterocyclic structure made up of benzene and pyrazole rings. Indazoles are an important class of heterocyclic compounds with a wide range of application as biologic and pharmaceutic agents. Indazole derivatives have a wide range of biological activities. For instance, indazole derivatives show vasorelaxant and anti-aggregator activities by stimulating NO release and increasing cGMP levels. Recent medical research and development studies resulted in the production of indazole derivatives for the treatment of osteoporosis, inflammatory diseases and neurodegenerative disorders. 4-bromo-1H indazole molecule is a much stronger inhibitor of 6-bromo-1H indazole and 7-bromo-1H indazole. 4-Bromo-1H-indazole may be strong inhibitor candidate for LPO and that caution should be exercised when using medicines containing indazole derivatives[1].

공급사100 곳

衢州润东化工有限公司0570-8789886 18892685668 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
爱斯特(成都)生物制药股份有限公司+86-28-85122536 85324413 · [email protected]
天津奕星生物科技有限公司022-82103883 18100103827
上海超悦化学科技有限公司(原上海斯比德化学)21-65679720 · [email protected]

관련 반응

52건

화합물 노트

불러오는 중…